147 related articles for article (PubMed ID: 35787557)
1. Retinol-binding protein-4 and nonalcoholic fatty liver disease.
Huang H; Xu C
Chin Med J (Engl); 2022 May; 135(10):1182-1189. PubMed ID: 35787557
[TBL] [Abstract][Full Text] [Related]
2. The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease.
Karamfilova V; Gateva A; Alexiev A; Zheleva N; Velikova T; Ivanova-Boyanova R; Ivanova R; Cherkezov N; Kamenov Z; Mateva L
Arch Physiol Biochem; 2022 Feb; 128(1):217-222. PubMed ID: 31588816
[TBL] [Abstract][Full Text] [Related]
3. The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis.
Hu R; Yang X; He X; Song G
Lipids Health Dis; 2023 Jan; 22(1):8. PubMed ID: 36670387
[TBL] [Abstract][Full Text] [Related]
4. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease.
Wang X; Chen X; Zhang H; Pang J; Lin J; Xu X; Yang L; Ma J; Ling W; Chen Y
Diabetes Metab; 2020 Apr; 46(2):119-128. PubMed ID: 31078721
[TBL] [Abstract][Full Text] [Related]
5. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
[TBL] [Abstract][Full Text] [Related]
6. Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A community-based cross-sectional study.
Chen X; Shen T; Li Q; Chen X; Li Y; Li D; Chen G; Ling W; Chen YM
Sci Rep; 2017 Mar; 7():45100. PubMed ID: 28332619
[TBL] [Abstract][Full Text] [Related]
7. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Zhou Z; Chen H; Ju H; Sun M
Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
[TBL] [Abstract][Full Text] [Related]
8. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
9. Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis.
Liu Y; Mu D; Chen H; Li D; Song J; Zhong Y; Xia M
J Clin Endocrinol Metab; 2016 Nov; 101(11):4338-4348. PubMed ID: 27504850
[TBL] [Abstract][Full Text] [Related]
10. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
[TBL] [Abstract][Full Text] [Related]
11. Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study.
Chang X; Yan H; Bian H; Xia M; Zhang L; Gao J; Gao X
Lipids Health Dis; 2015 Apr; 14():28. PubMed ID: 25890223
[TBL] [Abstract][Full Text] [Related]
12. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
Huang SC; Yang YJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
[TBL] [Abstract][Full Text] [Related]
13. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
[TBL] [Abstract][Full Text] [Related]
14. Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease.
Alkhouri N; Lopez R; Berk M; Feldstein AE
J Clin Gastroenterol; 2009; 43(10):985-9. PubMed ID: 19525859
[TBL] [Abstract][Full Text] [Related]
15. Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease.
Cai H; Lu S; Chen Y; Das Mbbs Mrcog S; Niu Z; Zhuo G; Lai L; Zhang Z
Clin Biochem; 2018 Jun; 56():95-101. PubMed ID: 29679552
[TBL] [Abstract][Full Text] [Related]
16. Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice.
Tan Y; Sun LQ; Kamal MA; Wang X; Seale JP; Qu X
Biochim Biophys Acta; 2011 Dec; 1811(12):1045-53. PubMed ID: 21983273
[TBL] [Abstract][Full Text] [Related]
17. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
[TBL] [Abstract][Full Text] [Related]
19. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease.
Seo JA; Kim NH; Park SY; Kim HY; Ryu OH; Lee KW; Lee J; Kim DL; Choi KM; Baik SH; Choi DS; Kim SG
Clin Endocrinol (Oxf); 2008 Apr; 68(4):555-60. PubMed ID: 17941908
[TBL] [Abstract][Full Text] [Related]
20. Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease.
Tönjes A; Blüher M; Stumvoll M
Curr Pharm Des; 2010 Jun; 16(17):1921-8. PubMed ID: 20370670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
